Cytotec (misoprostol) is a synthetic prostaglandin originally developed to treat stomach ulcers, but it is now widely used in obstetric care for three main purposes: inducing labor, managing early pregnancy loss, and ending a pregnancy through medication abortion. Its ability to soften the cervix and trigger uterine contractions makes it one of the most commonly used drugs in pregnancy-related care worldwide, even though most of these uses are technically off-label.
How Cytotec Works on the Uterus
Misoprostol mimics a naturally occurring hormone-like substance called prostaglandin E. It binds to specific receptors found abundantly in uterine tissue, particularly one called the EP3 receptor, which triggers two key responses: it softens and dilates the cervix (a process called cervical ripening), and it stimulates the uterine muscle to contract. These are the same processes the body uses during natural labor, which is why misoprostol can effectively jump-start or speed up delivery.
The drug can be given by mouth, placed under the tongue, or inserted vaginally, and each route has a different speed and duration. Oral misoprostol begins working in about 8 minutes but its effect fades within roughly 2 hours. Sublingual dosing kicks in around 11 minutes and lasts about 3 hours. Vaginal administration takes longer to start, around 20 minutes, but produces the longest-lasting effect at about 4 hours, with sustained, regular contractions. This is why clinicians choose different routes depending on the clinical goal.
Inducing Labor
The most common obstetric use of Cytotec is cervical ripening and labor induction when a pregnancy needs to be delivered but the cervix isn’t ready on its own. This might happen when a pregnancy goes past its due date, when the amniotic sac breaks before contractions start, or when a medical condition makes continued pregnancy risky for the mother or baby.
For labor induction, misoprostol is typically given in small doses of 25 or 50 micrograms. The standard 100-microgram tablet is split into halves or quarters to achieve these doses. It can be administered orally, vaginally, or under the tongue, and doses may be repeated at intervals until contractions establish a regular pattern. The goal is a gradual buildup of uterine activity that dilates the cervix and moves labor forward, similar to what happens naturally.
It’s worth knowing that this use is off-label. The FDA originally approved Cytotec only for preventing stomach ulcers caused by anti-inflammatory painkillers. The FDA label actually carries a boxed warning stating that misoprostol given to pregnant women can cause uterine rupture, premature birth, or birth defects. Despite this warning, major medical organizations endorse its use for labor induction in appropriate clinical settings because decades of evidence support its effectiveness when dosed carefully and monitored properly.
Managing Miscarriage
When an early pregnancy stops developing but the body hasn’t expelled the tissue on its own, misoprostol offers an alternative to a surgical procedure. This situation, sometimes called a missed miscarriage or incomplete miscarriage, can leave someone waiting days or weeks for the process to complete naturally. Misoprostol speeds that process along.
The standard approach uses 800 micrograms of misoprostol placed vaginally. In the largest U.S. trial on this use, 71% of women experienced complete expulsion within three days after a single dose. If the first dose didn’t work, a second dose brought the overall success rate up to 84%. Adding a dose of mifepristone (a different medication) 24 hours before the misoprostol significantly improves outcomes, increasing the rate of complete expulsion by about 25% and cutting the likelihood of needing a follow-up surgical procedure by more than 60%.
For many people, medication management of miscarriage is preferable because it can be done at home, avoids anesthesia, and allows a sense of control over the timing. The cramping and bleeding that follow are essentially the body going through the physical process of the miscarriage, compressed into a shorter window.
Medication Abortion
Misoprostol is one half of the two-drug regimen approved by the FDA for ending a pregnancy through ten weeks of gestation. The protocol works like this: on day one, a 200 mg tablet of mifepristone is taken by mouth. This drug blocks the hormone progesterone, which the pregnancy needs to continue. Then, 24 to 48 hours later, 800 micrograms of misoprostol is placed between the cheek and gum (buccal administration), where it dissolves and is absorbed. The misoprostol causes the uterus to contract and expel the pregnancy tissue. A follow-up appointment is scheduled about 7 to 14 days later to confirm the process is complete.
Misoprostol can also be used on its own for abortion without mifepristone, though this is less effective. The two-drug combination is the standard of care.
Postpartum Hemorrhage
After delivery, misoprostol is sometimes used to treat serious bleeding that occurs when the uterus doesn’t contract firmly enough on its own. By stimulating uterine contractions, the drug helps compress the blood vessels at the site where the placenta was attached. This use is particularly important in settings where other medications or surgical options aren’t readily available, making misoprostol a critical tool in global maternal health.
Side Effects
The most common side effects of misoprostol are diarrhea and stomach cramping, which stem from its original role as a gastrointestinal drug. When used in pregnancy-related care, chills and shivering are very common and can be intense enough to feel alarming, though they’re temporary and not dangerous. Fever, nausea, and headache also occur. These side effects generally resolve within a few hours as the drug is metabolized.
The most serious risk in obstetric use is uterine hyperstimulation, where the uterus contracts too frequently or too intensely. In rare cases, this can progress to uterine rupture, a life-threatening tear in the uterine wall. The risk of rupture is highest in women who have had a previous cesarean section or other uterine surgery, and it increases with later gestational ages. In one study of women with one prior cesarean, the rupture rate with misoprostol induction was 0.8%, comparable to the 1.1% rate seen with the more traditional induction drug oxytocin. However, both rates were higher than the rupture rate during spontaneous labor. For this reason, misoprostol is generally not used for labor induction in the third trimester if someone has a history of cesarean delivery or major uterine surgery.
Why the FDA Label Says One Thing and Doctors Do Another
The disconnect between Cytotec’s FDA-approved use (stomach ulcers) and its widespread obstetric use confuses a lot of people. Off-label prescribing is legal and common across medicine. It simply means a drug is being used for a purpose other than what was listed on its original approval. In this case, the evidence supporting misoprostol for cervical ripening, labor induction, miscarriage management, and abortion is extensive and endorsed by the American College of Obstetricians and Gynecologists. The FDA’s boxed warning reflects real risks, particularly uterine rupture, but those risks are managed through careful dosing, patient selection, and hospital monitoring during labor induction. The warning is not a prohibition; it’s a caution that these uses require trained medical oversight.